ICD-10-CM Billable Code

H16.401

Unspecified corneal neovascularization, right eye

Clinical Classification Guidelines

Medical Intelligence & Overview

Corneal neovascularization involves the growth of new blood vessels into the cornea, which is the clear, dome-shaped surface covering the front of the eye. When these blood vessels develop abnormally in the cornea of the right eye and are unspecified, it indicates that the exact cause or type has not been specifically identified. This condition can impact vision and eye health if left untreated, but it is often a response to chronic eye irritation or injury.

Causes & Symptoms

Clinical Causes: Chronic eye inflammation or infection Hypoxia or oxygen deprivation of the cornea Prolonged contact lens wear, especially poorly fitting or unclean lenses Corneal injuries or surgeries Exposure to environmental irritants or toxins Certain ocular surface diseases

Key Symptoms: Redness in the affected eye Decreased or blurred vision Feeling of heaviness or irritation in the eye Light sensitivity Discomfort or foreign body sensation Visible blood vessels on the corneal surface

Diagnostic & Treatment

Diagnosis Path: Diagnosis typically involves a comprehensive eye examination by an eye care professional, including visual acuity tests and slit-lamp examination to observe the corneal surface. Imaging techniques such as anterior segment optical coherence tomography (AS-OCT) or corneal fluorescein angiography may be used to assess the extent of neovascularization and confirm the diagnosis. Since the condition is labeled as 'unspecified,' the healthcare provider may also investigate underlying causes to clarify the diagnosis.

Treatment Protocols: Managing corneal neovascularization aims to address the underlying cause and prevent progression. Treatment options may include: - **Medications:** Use of topical steroids or anti-inflammatory eye drops to reduce inflammation. - **Laser therapy:** Laser ablation to destroy abnormal blood vessels. - **Surgical procedures:** Such as corneal transplantation in severe cases. - **Addressing causes:** Correcting contact lens issues, managing infections, or limiting exposure to irritants. Early intervention can be beneficial in preventing complications and preserving vision. It is advisable to follow an ophthalmologist’s guidance for personalized treatment options.

Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.

Clinical Advice & FAQs

Billing Guidance

Is H16.401 a billable ICD-10 code?
Yes, H16.401 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.

Documentation

How do I report H16.401?
Clinical documentation must specify the nature of Unspecified corneal neovascularization, right eye and any associated comorbidities for accurate reporting.

Cite this Clinical Reference